The independent source for health policy research, polling, and news.
41 - 60 of 112,362 Results
Democrat Xavier Becerra, a former U.S. health secretary, and Republican Steve Hilton were neck-and-neck Wednesday morning, but full results could take many days or weeks. In other government news, the U.S. House of Representatives approved a major increase in benefits for some of the nation's most catastrophically disabled veterans, Military.com reported.
The government is looking to assess the advanced cyber capabilities of AI models ahead of their full release to the public in an attempt to benchmark the process, CNBC reports. Plus: weight-loss drugs and cancer prevention; genetic therapies for brain disease research; and more.
According to The New York Times, Secretary of State Marco Rubio has indicated that the United States may resume funding of Gavi, a global vaccines alliance that provides immunizations for low-income nations. Gavi maintains the global Ebola vaccine stockpile. Health Secretary Robert F. Kennedy Jr. has blocked funding for it.
Public health experts note the "medical frailty" exemption, and specifically the bureaucratic red tape it will create, will lead to even more people losing their Medicaid coverage. “This is where we’ll see large and harmful coverage losses,” one public health expert told Stat.
Today's early morning highlights from the major news organizations.
Opinion writers weigh in on these topics and others.
The Washington Post reports on a previously unreleased settlement agreement between Texas Attorney General Ken Paxton, a Republican, and the Houston hospital, which is the nation’s largest pediatric hospital. The clinic will provide surgery, fertility counseling, and therapy, among other services. Also: About 374,000 Californians canceled their Covered California marketplace health coverage during the first quarter of the year.
The message went out to about 50 hospitals, Stat reports, and comes as part of the company's effort to reduce what it calls duplicate discounts paid to participating hospitals. Other industry news is on pediatric prior authorization, telehealth, autism therapy, and more.
Florida’s lawsuit claims OpenAI and CEO Sam Altman prioritized commercial gain over user safety. Experts both inside and outside the company repeatedly warned about the dangers of the product that facilitates and encourages self-harm and violence, AP wrote.
FiercePharma reports on how Shionogi’s oral antiviral drug — sold under the name Xocova and available in Japan since 2022 — has been cleared by the FDA for post-exposure prophylaxis for U.S. adults and some adolescents who have been exposed to covid. This makes it the first post-exposure covid oral drug approved in the United States.
The Bundibugyo strain of the Ebola virus has no targeted vaccine or therapeutics, CIDRAP reports. Experts say that the outbreak, which is already the third-largest in history, is likely much worse than official numbers suggest.
The guidance to states indicates pregnant women, parents of young children, veterans with disabilities, and people who are “medically frail” are among the Medicaid enrollees who may be exempt from work requirements, but not people who are homeless, NBC reports. Also: The Trump administration has been blocked from removing currently enlisted transgender service members.
Today's early morning highlights from the major news organizations.
Opinion writers weigh in on these topics and others.
Emails and records released by the Justice Department indicate Epstein had been banking his DNA for at least several years, but it's unclear whether it is still being preserved, The New York Times reported. One law expert told The Times that the issue of whether it is ethical for a facility to accept sperm from a sex offender is an ongoing debate in the fertility industry.
Results of the long-awaited clinical trial of the drug daraxonrasib were presented Sunday at the American Society of Clinical Oncology’s meeting in Chicago. “Unprecedented,” “compelling,” and “spectacular” are some of the words being used to describe the results, The Washington Post reports.
The FDA expanded the approved use for the inhaled insulin drug Afrezza on Friday. ABC News reports it is now approved for kids 6 years and older with Type 1 diabetes or those who require insulin with Type 2 diabetes. Plus: AI use as a diagnostic tool; Massachusetts vs. UnitedHealthcare in alleged Medicaid fraud case; and more.
Meta, TikTok, Snap Inc., and YouTube all settled with Kentucky's Breathitt County School District, avoiding a trial, Bloomberg reports, adding that more than 1,300 other school districts have filed similar lawsuits and are awaiting trial.
“Protecting Kenyans requires more than hoping diseases do not cross our borders,” the nation's Health Ministry said in a statement over the weekend. Kenyan health officials said Sunday that the facility is for "everyone," not just Americans. Plus: Suspected Ebola cases in Brazil and Italy are being investigated; the recovery of five patients prompts hope; and more.
In an executive order on Friday, President Donald Trump endorsed the new schedule, which reduces the number of recommended childhood vaccinations from 17 to 11, The Hill reports. Meanwhile, ProPublica reports on how efforts to combat gun violence have changed under the Trump administration.
© 2026 KFF